NCT00594633 2016-01-14Adjunctive Donepezil Therapy and Genetic Risk Factors of Cognitive Dysfunction in Brain Tumor SurvivorsMemorial Sloan Kettering Cancer CenterPhase 1 Completed25 enrolled